Overview
Protein Metrics provides vendor-neutral mass spectrometry software for comprehensive protein and oligonucleotide analysis throughout biopharmaceutical development. The platform offers instrument-agnostic solutions trusted by over 200 biopharmaceutical companies and 300 academic institutions for protein characterization, quantification, and reporting. Their Byos desktop and Byosphere cloud-based platforms enable rapid analysis of complex protein mixtures, host cell protein detection, and multi-protein quantitation workflows processing gigabytes of data.
Frequently asked questions
- What mass spectrometry platforms does Protein Metrics support?
- Protein Metrics provides instrument-agnostic mass spectrometry software that works with data generated on all major commercially available mass spectrometry platforms, allowing researchers to use their existing instrumentation without vendor lock-in.
- What are the main software platforms offered?
- Protein Metrics offers Byos, a desktop software platform for comprehensive mass spectrometry analysis workflows, and Byosphere, a cloud-based platform that enables rapid comparison of data across samples, projects, and geographic sites in a GxP compliance-ready environment.
- What analytical capabilities does the software provide?
- The platform supports protein characterization, label-free quantitative analysis of thousands of proteins, multi-protein quantitation workflows, host cell protein analysis, peptide validation, PTM and cross-link analysis, sequence variant detection, disulfide mapping, and fold change reporting for comparative studies.
- How many proteins can be analyzed simultaneously?
- Protein Metrics' multi-protein quantitation workflows can quantify thousands of proteins from sample replicates while processing gigabytes of input data, with auto-curated analysis and protein-centric reporting capabilities.
- Is the software suitable for regulatory compliance?
- Yes, the Byosphere cloud platform is described as GxP compliance-ready, making it suitable for regulated biopharmaceutical environments from early cell line development through final drug purity verification.